Novartis India Limited operates as a healthcare company in India. It offers pharmaceutical products in the areas of bone and pain, calcium portfolio, gynecology, and neurosciences, as well as generics products in the areas of gynecology, anti-TB, and anti-infectives. The company provides central nervous system products under the Tegrital and Exelon brands; pain and inflammation products under the Voveran brand; and transplantation/immunology products under the Simulect, Certican, Myfortic, and Sandimmun Neoral brands. The company was incorporated in 1947 and is headquartered in Mumbai, India. Novartis India Limited is a subsidiary of Novartis AG.
Show more...
首席执行官
Mr. Sanjay Prabhakar Murdeshwar
员工
81
国家
IN
ISIN
INE234A01025
上市
0 Comments
分享你的想法
FAQ
Novartis India 今天的股价是多少?▼
NOVARTIND.NSE 当前价格为 ₹674 INR,在过去 24 小时内下跌了 -2.66%。在图表上更密切关注 Novartis India 股票的表现。
Novartis India 的股票代码是什么?▼
根据交易所不同,股票代码可能会有所不同。例如,在 交易所,Novartis India 的股票以代码 NOVARTIND.NSE 进行交易。